19 June 2013
Keywords: Affymax, Takeda, Hematide, Milestone, Research results
Article | 23 June 2010
California, USA-based Affymax has received $30 million in development milestone payments from Japan’s largest drugmaker, Takeda Pharmaceutical, as part of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 June 2010
© 2013 thepharmaletter.com